Biogen Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases. | ![]() Chiesi Group Chiesi Group (Gruppo Chiesi, also known as CHIESI Farmaceutici) is a company that researches, develops, produces, and commercializes therapeutic solutions. | |||
Founding Date | Founding Date 2016 | Founding Date 1904 | Founding Date 1978 | Founding Date 1935 |
Type | Type Public | Type Subsidiary | Type Public | Type Subsidiary |
Tags | ||||
Locations | Locations South San Francisco, US HQ | Locations King of Prussia, US HQ Broadmeadows, AU Parkville, AU Parkville, AU Wien, AT Mechelen, BE see more | Locations Cambridge, US HQ Vicente López, AR Macquarie Park, AU Wien, AT Machelen, BE São Paul, BR Toronto, CA see more | Locations Parma, IT HQ Melbourne, AU Wien, AT Machelen, BE Santana De Parnaíba, BR São Paulo, BR Sofia, BG see more |
Employees | Employees 4410% increase | Employees 7,5692% decrease | Employees 7,605 | Employees 5,8541% increase |
Valuation ($) | Valuation ($) 30.5 m | Valuation ($) N/A | Valuation ($) 26.7 b | Valuation ($) N/A |
Financial | ||||
Revenue (est.) | Revenue (est.) $3.5m (FY, 2025) | Revenue (est.) $7.9b (FY, 2020) | Revenue (est.) $9.9b (FY, 2025) | Revenue (est.) €2.4b (Y, 2021) |
Gross profit | Gross profit N/A | Gross profit $4.5b (FY, 2020) | Gross profit $7.5b (FY, 2025) | Gross profit N/A |
Net income | Net income ($242m) (FY, 2025) | Net income N/A | Net income $1.3b (FY, 2025) | Net income N/A |
Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases.
View company
Chiesi Group (Gruppo Chiesi, also known as CHIESI Farmaceutici) is a company that researches, develops, produces, and commercializes therapeutic solutions.
View company